Exchange: NASDAQ·Updated 02:59 PM EDT
BIAF logo

BIAF BioAffinity Technologies Inc

$3.68
$0.1659
(4.73%)
Today
Reported EarningsAug 7
Mkt Cap$4.5M
Vol77,834.00

About BIAF

bioAffinity Technologies, Inc. operates as a development-stage company addressing the significant unmet need for non-invasive, early-stage cancer diagnosis and treatment. The firm develops proprietary in-vitro diagnostic tests and targeted cancer therapeutics using breakthrough technology that preferentially targets cancer cells. The company was founded on March 26, 2014 and is headquartered in San Antonio, TX.
46

Neutral Sentiment

How do you feel about BIAF?

cjstocksup
$BIAF This should scare shorts to death, if longs understood the 2 post thread below, they would stop using the tight stop losses so we can really run above! That is why the shorts are screaming so loud!
2
4
cjstocksup
$BIAF As I said, now focus on $10.00 and $15.00 next. If you use trailing stop losses stop using 5% they have taken them all day long and slowed us, use a higher limit. JMO
3
1
cjstocksup
$BIAF Lots of trailing stops hit on this one. Let's see if we can get the float tight away from those traders for the most part for an $8.50 break later.
2
2
geg321
$BIAF the August financing agreement actually blocks BIAF from issuing or even announcing new common stock/common-stock equivalents until 90 days after the registration became effective. That registration became effective Sept. 4, so the lockout runs to roughly Dec. 3–4.
2
ahTony
$BIAF "BIAF - Will sponsor a Learning Theater presentation at CHEST 2026 on October 21, 2026, from 12:30-1:15 p.m. MST in Phoenix, Arizona. Chief Medical Officer Dr. Gordon Downie will discuss CyPath Lung's role in lung cancer risk stratification and pulmonary nodule management, along with positive research data supporting the development of an investigational test for asthma- and COPD-related lung inflammation."
3
kellyc09
$BIAF They just don’t seem to let these stocks run anymore. Cannot blame them for taking profits but feel it could be over $10 quickly if they just hold on.
5
Stock_Catcher
$BIAF bioAffinity Technologies Reports Over 100% Growth in CyPath® Lung Sales Through Third Quarter 2026
1
2
jmoonstocks
$BIAF If it can crack and hold 12.50 the next stop is obiously 15. Float = 600K. yes that 600,000 outstanding shares.$SPY
5
GJ_Rockabilt
$BIAF $MOBX BOTH at extreme lows. I Own them. Take your pick(s), if you have the tolerance. HOLDING!
4
Robcat
$BIAF Today, this ticker made me break discipline strategy. I could not temp buying more cheap shares as of now. I will keep buying tomorrow if MMS keeps dragging down: Very simple reason: Dillution price is 6.11. Don't believe it will tank to ZERO.
4
R_NW
$BIAF wtf! what is wrong with management, I don' know if it is arrogance or foolishness? How can they keeping fn shareholders? If they don't know what to do, merge or sellout to the highest bidder. Great product, sh*t CEO.
4
JMJTrading
$BIAF I cant stand offerings mid-day. I made some money trading this earlier, but if I was in during the offering drop I would be pissed. I mean take a look at $DXI.X $SXTC & $SBFM - it could be worse, brutal today. I'm only holding $QTEX going into tomorrow. Good luck all, more calls tomorrow.
1
1
skinnyflynny
$BIAF Stocktwits is a great confessional. I didn't stick to my rules. This trade didn't check all the criteria's I've set. I guessed and now i have to pay. I'll Learn from it. I'll make it the last time. I'll Be better. GL Bulls and Bears.
4
Bangerplays
$BIAF we will look to add $6-$5.80 for cat bounce if it shows a little support which it most likely will
1
1
Trading_Edge
$BIAF — bioAffinity is trying to push its CyPath Lung test deeper into the federal healthcare market. The company recently debuted its distribution partnership with veteran-owned AvMEDICAL in front of VA physicians and administrators.
4
AlwaysABullNeverABear
$BIAF bioAffinity Technologies is advancing CyPath Lung, a noninvasive AI-driven sputum test for early lung cancer detection, targeting high-risk patients and veterans through CLIA-regulated laboratory deployment and strategic outreach. On September 30, 2026, bioAffinity and veteran-owned AvMEDICAL debuted their federal distribution partnership for CyPath Lung at the NAVREF conference, aiming to expand veterans’ access via VA channels and lung cancer screening networks.
1
1
TooMuchSeaWater
$BIAF gimme contract news, I thought BIAF will drop to $2.50 soon but I was wrong. It’s holding pretty nice above $3. Feels a storm coming soon after CHEST event
2
Stock_Catcher
$BIAF bioAffinity Technologies to Present New Perspectives on CyPath® Lung’s Use for Cancer Risk Assessment at CHEST 2026
3
focafoca99
$BIAF expects to present new sputum-based lung inflammation data at CHEST 2026 conference.
1
jmoonstocks
$BIAF With the offerin gprice at 6.12 i bought some at 4 and will buy more if they want to take it to 3.50.
3

Advertisement|Remove ads.